AmeriCann’s Massachusetts Cannabis Center Featured on CNN Special Report
AmeriCann’s Massachusetts Cannabis Center Featured on CNN Special Report
Dr. Sanjay Gupta's Award-winning Series WEED 6: Marijuana and Autism Will Broadcast Again on Friday, Dec. 24 at 6 P.M. EST
Sanjay Gupta博士的獲獎系列《大麻6：大麻和自閉症》將於12月24日(星期五)美國東部時間下午6點再次播出。
BOSTON, Dec. 22, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- AmeriCann Inc. (OTCQB:ACAN) (the "Company"), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, announced that the Company's Massachusetts Cannabis Center was featured on the award-winning series by Dr. Sanjay Gupta on CNN exploring cannabis treatments for autism.
波士頓，2021年12月22日(環球通訊社)--Via InvestorWire--americann Inc.(場外交易市場代碼：ACAN)是一家開發最先進種植、產品製造和分銷設施的大麻公司(以下簡稱“公司”)，該公司宣佈，該公司的馬薩諸塞州大麻中心出現在桑傑·古普塔(Sanjay Gupta)博士在CNN節目中探索自閉症大麻療法的獲獎系列節目中。
"For nearly a decade Dr. Sanjay Gupta's breakthrough series has shattered myths and introduced the healing properties of cannabis on a global stage," stated AmeriCann CEO Tim Keogh. "We are proud to play a role in helping Dr. Gupta present the considerable benefits that severe autism patients have achieved being treated with cannabis."
“近十年來，桑賈伊·古普塔博士的突破性系列打破了神話，並在全球舞臺上介紹了大麻的治療作用，”americann首席執行官蒂姆·基奧(Tim Keogh)説。我們為能在幫助古普塔博士展示嚴重自閉症患者接受大麻治療所獲得的巨大好處方面發揮作用而感到自豪。“
AmeriCann hosted the CNN film crew earlier this year in Building 1 of the Company's flagship project, the Massachusetts Cannabis Center.
今年早些時候，American ann在該公司旗艦項目馬薩諸塞州大麻中心(Massachusetts Cannabis Center)的1號樓接待了CNN攝製組。
AmeriCann's Massachusetts Cannabis Center is located on a 52-acre parcel in southeastern Massachusetts. The project is permitted for 987,000 square feet of cannabis cultivation and processing infrastructure, which is being developed in phases, and will support multiple tenants in both the existing medical and adult-use cannabis markets.
美國人的馬薩諸塞州大麻中心位於馬薩諸塞州東南部一塊佔地52英畝的地塊上。該項目允許提供98.7萬平方英尺的大麻種植和加工基礎設施，該基礎設施正在分階段開發，並將支持現有醫用和成人用大麻市場的多個租户。
The initial phase of the development, Building 1, is a fully operational 30,000-square-foot cultivation greenhouse and processing facility that utilizes AmeriCann's proprietary "Cannopy" cultivation system.
開發的第一階段，1號樓，是一個完全投入使用的3萬平方英尺的栽培温室和加工設施，利用americann專有的“Cannopy”種植系統。
AmeriCann recently released a video highlighting the high-tech, sustainable designs at the Massachusetts Cannabis Center and Building 1 which can be found HERE.
美國人最近發佈了一段視頻，重點介紹了馬薩諸塞州大麻中心和1號樓的高科技、可持續設計，這些設計可以在這裏找到。
About AmeriCann
AmeriCann (OTCQB:ACAN) develops and leases cannabis cultivation, processing and product manufacturing facilities.
關於美國人
Americann(場外交易市場代碼：ACAN)開發和租賃大麻種植、加工和產品製造設施。
AmeriCann uses greenhouse technology which is superior to the current industry standard of growing cannabis in warehouse facilities under artificial lights. According to industry experts, by capturing natural sunlight, greenhouses use 25 percent fewer lights, and utility bills are up to 75 percent less than in typical warehouse cultivation facilities. As such, AmeriCann's Cannopy System enables cannabis to be produced with a greatly reduced carbon footprint, making the final product less expensive. Additionally, greenhouse construction costs are nearly half of warehouse construction costs.
美國人使用的温室技術優於目前的行業標準，即在人造燈光下在倉庫設施中種植大麻。根據行業專家的説法，通過捕捉自然陽光，温室使用的燈光減少了25%，公用事業賬單比典型的倉庫種植設施減少了75%。因此，americann的Cannopy系統使大麻的生產大大減少了碳足跡，從而降低了最終產品的成本。此外，温室建設成本幾乎佔倉庫建設成本的一半。
AmeriCann is also designing GMP Certified cannabis extraction and product manufacturing infrastructure. The Company has secured licenses to produce cannabis infused products including beverages, edibles, topicals and concentrates. AmeriCann plans to operate a marijuana product manufacturing business at the Massachusetts Cannabis Center.
美國人還在設計GMP認證的大麻提取和產品製造基礎設施。該公司已經獲得了生產注入大麻的產品的許可證，包括飲料、食品、外用藥物和濃縮物。Americann計劃在馬薩諸塞州大麻中心經營一家大麻產品製造企業。
Forward-Looking Statements
前瞻性陳述
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words "believe," "anticipate," "estimate," "expect," "intend," "plan," "project," "prospects," "outlook," and similar words or expressions, or future or conditional verbs such as "will," "should," "would," "may," and "could" are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional uncertainties that could impact the Company's forward-looking statements, please see the Company's Registration Statement on Form S-1 which may be viewed at www.sec.gov.
本新聞稿包含修訂後的1933年證券法第27A節和修訂後的1934年證券交易法(“交易法”)第21E節所指的“前瞻性陳述”(這兩節被採納為1995年私人證券訴訟改革法的一部分)。在“相信”、“預期”、“估計”、“預期”、“打算”、“計劃”、“項目”、“展望”、“展望”以及類似的詞語或表達，或未來或條件動詞，如“將”、“應該”、“將”、“可能”和“可能”等詞語之前、之後或以其他方式包括“相信”、“預期”、“估計”、“預期”、“打算”、“計劃”、“項目”、“展望”和“展望”等詞語的陳述，一般都是前瞻性的，而不是歷史事實。這些前瞻性陳述涉及已知和未知的風險、不確定因素和其他因素，這些風險、不確定因素和其他因素可能導致公司的實際結果、業績或成就與任何預期的結果、業績或成就大不相同。無論是由於新信息、未來事件或其他原因，公司沒有任何修改任何前瞻性陳述的意圖，也沒有義務修改任何前瞻性陳述。有關可能影響公司前瞻性陳述的其他不確定因素，請參閲公司S-1表格中的註冊聲明，該聲明可在www.sec.gov上查看。
Contact Information:
Corporate:
info@americann.co
@ACANinfo on Twitter
@AmeriCann on Facebook
@AmeriCannInc on Instagram
聯繫方式：
公司：
郵箱：info@americann.co
@Twitter上的ACANinfo
@Facebook上的@americann
@ameriCannInc.在Instagram上
Corporate Communications
IBN (InvestorBrandNetwork)
Los Angeles, California
310.299.1717 Office
Editor@InvestorBrandNetwork.com
企業通信
IBN(InvestorBrandNetwork)
加利福尼亞州洛杉磯
310.299.1717辦事處
電子郵箱：Editor@InvestorBrandNetwork.com